Cognitive Function and Brain Connectivity in CAS Patients:a Rs-fMRI Study

Cognitive Function and Brain Connectivity in Carotid Artery Stenting Patients:a Rs-fMRI Study

This is a prospective study aimed to explore the changes of cognitive function after surgery for CAS and the correlation with brain connectivity, in order to look for the clinical biomarkers to predict the carotid stent implantation for patients which can effect the cognition

Study Overview

Status

Recruiting

Detailed Description

Carotid artery stenting (CAS) can significantly decrease the incidence of ischemic stroke in patients with severe carotid artery stenosis has been confirmed in large randomized controlled studies (1, 2).Previous studies showed carotid artery stenosis is closely related to cognitive dysfunction, including asymptomatic carotid artery stenosis(≥70%).Cognitive impairment is one of the most serious problem facing the elderly. The impact on cognitive function in patients with CAS has been discussed by many researchers, however the effect still remained conflicting.

In past few years, several imaging techniques, such as resting-state functional MRI (R-fMRI), had been increasingly used to study cognitive impairment in humans. In this study, we evaluated the cognition performance in severe carotid artery stenosis patients undergoing CAS and explored the mechanisms underlying the cognition changes by the Rs-fMRI.

Inclusion criteria:

  • age between 55 years and 80 years
  • unilateral internal carotid artery stenotic degree ≥ 70%
  • right-hand-dominant
  • free of dementia, and depression
  • modified Rankin Scale: 0 or 1
  • education ≥6 years
  • obtained written informed consent.

Exclusion criteria:

  • contralateral internal carotid artery stenosis ≥ 50%
  • posterior circulation diseases
  • MMSE < 26, which is a cut-off value for mild cognitive impairment
  • severe systemic diseases and neuropsychiatric diseases (such as congestive heart failure)
  • any contraindications for MRI scan (e.g., metal implants)
  • Non atherosclerotic stenosis, such as dissection, vasculitis.

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310016
        • Recruiting
        • The First Affiliated Hospital of Zhejiang University
        • Principal Investigator:
          • Benyan Luo, PhD
        • Contact:
          • 仁杰 计
          • Phone Number: 13738101002

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

consecutive enrolled patients with carotid artery stenosis who undergoing carotid artery stenting

Description

Inclusion Criteria:

  • age between 55 years and 80 years
  • unilateral internal carotid artery stenotic degree ≥ 70%
  • right-hand-dominant
  • free of stroke, TIA, dementia, and depression
  • modified Rankin Scale: 0 or 1
  • education ≥6 years
  • obtained written informed consent.

Exclusion Criteria:

  • contralateral internal carotid artery stenosis ≥ 50%
  • posterior circulation diseases
  • MMSE < 26, which is a cut-off value for mild cognitive impairment
  • severe systemic diseases and neuropsychiatric diseases (such as congestive heart failure and history of stroke)
  • any contraindications for MRI scan (e.g., metal implants)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Montreal Cognitive Assessment, MOCA
Time Frame: before CAS(within 1 week)
use MOCA to assess the cognition before CAS
before CAS(within 1 week)
Mini-mental State Examination,MMSE
Time Frame: before CAS(within 1 week)
use MMSE to assess the cognition before CAS
before CAS(within 1 week)
Montreal Cognitive Assessment, MOCA
Time Frame: 3 months after CAS
use MOCA to assess the cognition after CAS
3 months after CAS
Mini-mental State Examination,MMSE
Time Frame: 3 months after CAS
use MMSE to assess the cognition after CAS
3 months after CAS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Digit Symbol Test
Time Frame: before CAS(within 1 week)
use to assess the cognition before CAS
before CAS(within 1 week)
Digit Symbol Test
Time Frame: 3 months after CAS
use to assess the cognition after CAS
3 months after CAS
Trail Making Test A/B
Time Frame: before CAS(within 1 week)
use to assess the cognition before CAS
before CAS(within 1 week)
Trail Making Test A/B
Time Frame: 3 months after CAS
use to assess the cognition after CAS
3 months after CAS
digital span test
Time Frame: before CAS(within 1 week)
use to assess the cognition before CAS
before CAS(within 1 week)
digital span test
Time Frame: 3 months after CAS
use to assess the cognition after CAS
3 months after CAS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Benyan Luo, PhD, Zhejiang University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2021

Primary Completion (Anticipated)

June 30, 2022

Study Completion (Anticipated)

July 1, 2022

Study Registration Dates

First Submitted

December 27, 2021

First Submitted That Met QC Criteria

March 14, 2022

First Posted (Actual)

March 23, 2022

Study Record Updates

Last Update Posted (Actual)

March 23, 2022

Last Update Submitted That Met QC Criteria

March 14, 2022

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carotid Artery Stenosis

3
Subscribe